Product
fetal hemoglobin induction therapies
BIOTECHNOLOGY
byIMMvention Therapeutix, Inc.
United States (US)
ABOUT THE PRODUCT
Research and development of therapies designed to induce fetal hemoglobin production, offering a potential treatment for sickle cell disease.
Information is owner-confirmed
Last updated 0 month ago
Price range